Dr Christopher Southan

Chris has a PhD from the LMU Munich, MSc in Virology from Reading and BSc Hons in Biochemistry from Dundee. His background in protein chemistry, bioinformatics, cheminformatics, drug discovery and pharmacology were acquired in both commercial and academic roles. Recent positions include Senior Cheminformatian for the Edinburgh University BPS/IUPHAR Guide to Pharmacology (2013-18 and 2020). He is the owner of TW2Informaics for consuting worlk (2011-12, 2019-20) and as a contractor for the AstraZeneca Knowledge Engineering Program (2009-11) and ELIXIR Database Provider Survey Coordinator at the EBI (2008-9). These were preceded by a Principle Scientist and Bioinformatics Team Leader position in AstraZeneca, Sweden (2004-7) and senior bioinformatician positions in the UK at Oxford Glycosciences Gemini Genomics and SmithKline Beecham. He has 109 PubMed entries (ORCID 0000-0001-9580-04) is on several journal boards including Pharmacology Research and Perspectives. He is an Honorary Fellow, University of Edinburgh and Adjunct Associate Professor, University of New Mexico.